Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
7.68
-0.86 (-10.13%)
At close: Dec 5, 2025, 4:00 PM EST
7.70
+0.02 (0.32%)
After-hours: Dec 5, 2025, 7:04 PM EST
Biodesix Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Revenue | 80.17 | 71.32 | 49.09 | 38.21 | 54.51 | 45.56 | Upgrade
|
| Revenue Growth (YoY) | 22.29% | 45.30% | 28.46% | -29.89% | 19.64% | 85.55% | Upgrade
|
| Cost of Revenue | 16.18 | 15.57 | 13.01 | 14.15 | 30.52 | 22 | Upgrade
|
| Gross Profit | 63.99 | 55.75 | 36.08 | 24.06 | 23.99 | 23.56 | Upgrade
|
| Selling, General & Admin | 84.79 | 80.45 | 67.39 | 61.46 | 50.52 | 34.86 | Upgrade
|
| Research & Development | 11.55 | 9.56 | 9.99 | 13.1 | 12.79 | 10.82 | Upgrade
|
| Operating Expenses | 96.34 | 90.01 | 77.38 | 74.56 | 63.31 | 45.68 | Upgrade
|
| Operating Income | -32.35 | -34.26 | -41.3 | -50.51 | -39.32 | -22.12 | Upgrade
|
| Interest Expense | -7.41 | -8.26 | -9.54 | -8.07 | -4.51 | -7.6 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.43 | 0.07 | -1.27 | 0.19 | -0.01 | -0.81 | Upgrade
|
| EBT Excluding Unusual Items | -39.33 | -42.45 | -52.1 | -58.39 | -43.84 | -30.53 | Upgrade
|
| Asset Writedown | -0.21 | -0.24 | -0.04 | -0.08 | - | - | Upgrade
|
| Other Unusual Items | - | -0.25 | - | -6.98 | 0.68 | -0.82 | Upgrade
|
| Pretax Income | -39.54 | -42.93 | -52.15 | -65.45 | -43.16 | -31.35 | Upgrade
|
| Net Income | -39.54 | -42.93 | -52.15 | -65.45 | -43.16 | -31.35 | Upgrade
|
| Net Income to Common | -39.54 | -42.93 | -52.15 | -65.45 | -43.16 | -31.35 | Upgrade
|
| Shares Outstanding (Basic) | 7 | 6 | 4 | 2 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 6 | 4 | 2 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | 27.43% | 57.92% | 95.03% | 53.86% | 465.63% | 1899.17% | Upgrade
|
| EPS (Basic) | -5.36 | -6.62 | -12.70 | -31.09 | -31.54 | -129.60 | Upgrade
|
| EPS (Diluted) | -5.36 | -6.62 | -12.70 | -31.09 | -31.54 | -129.60 | Upgrade
|
| Free Cash Flow | -29.16 | -51.88 | -45.79 | -48.27 | -30.46 | -24.06 | Upgrade
|
| Free Cash Flow Per Share | -3.95 | -8.00 | -11.15 | -22.93 | -22.27 | -99.47 | Upgrade
|
| Gross Margin | 79.82% | 78.17% | 73.50% | 62.96% | 44.01% | 51.71% | Upgrade
|
| Operating Margin | -40.34% | -48.03% | -84.13% | -132.17% | -72.14% | -48.55% | Upgrade
|
| Profit Margin | -49.31% | -60.19% | -106.23% | -171.27% | -79.18% | -68.81% | Upgrade
|
| Free Cash Flow Margin | -36.37% | -72.74% | -93.28% | -126.32% | -55.89% | -52.81% | Upgrade
|
| EBITDA | -26.61 | -28.49 | -37.97 | -46.91 | -36.14 | -19.21 | Upgrade
|
| EBITDA Margin | -33.20% | -39.94% | -77.35% | -122.76% | -66.31% | -42.17% | Upgrade
|
| D&A For EBITDA | 5.73 | 5.77 | 3.33 | 3.6 | 3.18 | 2.9 | Upgrade
|
| EBIT | -32.35 | -34.26 | -41.3 | -50.51 | -39.32 | -22.12 | Upgrade
|
| EBIT Margin | -40.34% | -48.03% | -84.13% | -132.17% | -72.14% | -48.55% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.